Introduction {#sec1}
============

Abdominal aortic aneurysm (AAA) is defined as a localized enlargement of the aortic cross-section where the diameter is greater than 3 cm or more than 50% larger than the diameter in a normal segment. The etiology of AAA is usually complex, involving both environmental and genetic factors. Main AAA risk factors include age over 65, atherosclerosis regardless of localization, male sex, Caucasian ethnicity, smoking, family history, and hypertension \[[@cit0001], [@cit0002]\]. Most AAAs are located in the infrarenal region while juxtarenal aortic aneurysms account for 15% of cases \[[@cit0003]\]. It is estimated that aneurysms occur in 4--8% of men and 1--2% of women aged over 65 \[[@cit0004]--[@cit0006]\]. However, as in most patients the aneurysm remains asymptomatic and its detection is usually incidental, the actual prevalence of AAA is uncertain.

The most important complication of AAA is rupture, which, if untreated, results in mortality rates of up to 90% \[[@cit0002]\]. The major risk factors for aneurysm rupture include the diameter at the time of diagnosis, aneurysm size progression, and male gender \[[@cit0007]\]. Conventional open surgical repair was the gold standard for treatment of AAAs for more than 50 years but is associated with a significant 30-day mortality \[[@cit0008]\]. Endovascular aneurysm repair (EVAR) was proposed by Volodos *et al.* in 1987 \[[@cit0009]\] and then promoted by Parodi *et al.* \[[@cit0010]\]. As EVAR is a significantly less invasive procedure than open aneurysm repair, it is related to a lower early mortality rate and lower number of perioperative complications. Although EVAR is a minimally invasive technique, lifelong follow-up imaging is necessary due to possible late complications. Those include endoleak, recurrent aneurysm formation, graft infection, migration, kinking and thrombosis. The total rate of complications after EVAR is estimated at approximately 30%, and the rate of complications that require intervention is 2--3% \[[@cit0011]\]. Early detection and progression analysis of such situations is crucial for proper intervention.

Aim {#sec2}
===

The aim of this review was to discuss current imaging methods used for follow-up of patients after EVAR with special attention paid to the invasiveness of procedures.

Common complications of endovascular aneurysm repair {#sec3}
====================================================

Endoleak {#sec3.1}
--------

Endoleak is a basic and unique complication after EVAR and is a main contributor to aneurysm enlargement and potential rupture. In the classic definition of White *et al*. endoleak describes incomplete exclusion of the aneurysm sac by the graft \[[@cit0012]\]. Endoleak is frequent after EVAR and occurs in nearly one in four patients at some time during follow-up \[[@cit0013]\]. In most cases endoleaks remain asymptomatic. Therefore, lifelong surveillance following EVAR is suggested \[[@cit0014]\]. Classification of endoleaks is based on the source of blood flow into the space between the graft and the aneurysm wall. Correct classification is important because of different treatment strategies. Five different types of endoleaks are distinguished:

-   Type I is related to a leak at the incomplete attachment of the graft to the aortic lumen, which leads to pressure increase in the aneurysm sac; type Ia proximal, type Ib distal and type Ic related to inadequate seal of iliac occluder. This type of endoleak is associated with high risk of rupture and requires immediate treatment.

-   Type II endoleaks are considered most frequent, occurring in approximately 40% of all leaks \[[@cit0014]\]. They are caused by branch arteries of the aorta or iliac artery filling the aneurysm sac. Two subtypes are distinguished: IIa with one artery and IIb with multiple collateral arteries supplying the sac. Treatment is recommended in the case of enlargement of the aneurysm sac by more than 10 mm \[[@cit0013]\].

-   Type III endoleaks are characterized by EVAR graft mechanical failure. Two subtypes are distinguished: graft rupture (IIIa) and fabric disruption (IIIb). Type III endoleaks require active management.

-   Type IV endoleaks are usually detected in the early postoperative phase (first 30 days). They are caused by porous flow through the fabric of the graft. Type IV endoleaks are almost never seen in newer generation stent grafts.

-   Type V endoleaks refers to endotension, i.e. increase in size of the aneurysm sac without detectable endoleak. Type V endoleaks are idiopathic in nature and diagnosis is based on exclusion of type I--IV endoleaks.

Other complications {#sec4}
===================

Component separation and further dislocation were more prevalent in the first generation of stent grafts and may be caused by shrinkage of the aneurysm sac and increased pressure towards the graft's iliac limbs. Component separation may result in type III endoleak and device migration \[[@cit0013]\]. Device migration is a relatively common complication occurring in approximately 3% of patients \[[@cit0015]\]. Significant migration is defined as a dislocation of 5--10 mm relative to an anatomic landmark or any migration leading to symptoms or requiring intervention. Typical landmarks for comparison and assessment of migration are the superior mesenteric artery (SMA) and renal arteries. Migration can be asymptomatic, or can result in type I endoleak and a subsequent rupture. Stent graft migration can also result in branch vessel occlusion, usually renal arteries and internal iliac arteries. Major device migration increases the risk of intragraft thrombosis.

Graft kinking occurs in about 3% of patients after EVAR, more commonly after device distal migration with an intact distal attachments site \[[@cit0016]\]. Kinking can lead to type I and type III endoleak and is strongly associated with limb thrombosis due to turbulent flow in the kinked stent graft \[[@cit0017]\]. Stent graft thrombosis occurs usually in the first 2 months following surgery \[[@cit0018]\]. Frequency of stent-graft limb thrombosis strongly depends on the type of graft and ranges from 5% to 40% depending on the device type \[[@cit0017], [@cit0019], [@cit0020]\].

Graft infection is a rare complication of EVAR, occurring in less than 1% of patients, but is related to high mortality rates of 6--11% \[[@cit0021], [@cit0022]\]. Graft infection can lead to periaortic abscesses, aorto-enteric fistulas, and systemic sepsis \[[@cit0023]\]. Air within the aortic sac, mesenteric inflammation adjacent to the stent graft, perigraft fluid collections, and thrombus enhancement are imaging symptoms of graft infection in computed tomography (CT).

Access site complications include local wound complications and access artery injuries. Groin hematoma, infection, and lymphocele occur with a frequency of 1--10% \[[@cit0024]\]. They are usually diagnosed with ultrasound and CT is required only in advanced cases. Significant complications, including iliac artery dissection, thrombosis and pseudoaneurysm formation, occur in up to 3% and require CT imaging \[[@cit0017]\].

Imaging methods {#sec5}
===============

Imaging methods used in the post-EVAR surveillance include plain X-ray, ultrasound, computed tomography, magnetic resonance imaging, and conventional angiography. It seems important to understand the unique advantages and disadvantages of each modality to personalize diagnostics for optimal patient outcome.

Radiography {#sec5.1}
-----------

Plain radiography of the abdomen performed in anteroposterior and lateral projections is useful in the assessment of the graft position and integrity ([Photo 1](#f0001){ref-type="fig"}). Therefore, prosthesis migration, separation of modules, and wire fractures may be easily detected using radiography \[[@cit0025]\]. As the technique does not suffer from artifacts related to metallic objects, it can be even more sensitive to mechanical damage than cross-sectional modalities \[[@cit0013]\]. Obviously, plain radiographs do not allow for imaging of the aneurysm size and leaks so they cannot be used as a standalone method of follow-up \[[@cit0025]\].

![Plain abdominal radiograph presenting kinking of the left iliac arm of the graft (arrow)](WIITM-14-33975-g001){#f0001}

Ultrasound {#sec5.2}
----------

Conventional ultrasound (US) with Doppler option and contrast-enhanced ultrasound (CEUS) are less invasive but are considered less accurate than CT. However, in many centers US is the primary imaging method after EVAR ([Photo 2](#f0002){ref-type="fig"}). The US is a non-invasive and low-cost alternative to other diagnostic imaging modalities. The undeniable advantages of US are non-invasiveness, wide availability, low cost, and lack of ionizing radiation. The ability of Doppler US to identify flow direction in endoleaks is a great advantage over computed tomography angiography (CTA). Major disadvantages of US remain operator skill and technique dependency, equipment dependency and attenuation artifacts in large body habitus patients. There is still no consensus among researchers on the value of US in identifying the primary complication of EVAR, i.e. endoleak. According to various authors, the sensitivity of US in this regard ranges from 12% to 100% \[[@cit0026]--[@cit0031]\]. Those numbers underline the significant subjectivity of sonography and may be due to the different experience of observers, differences in ultrasound equipment quality, and the wide range of patients enrolled in studies (20--561 patients) \[[@cit0032]\].

![Patient presented in Photo 1. Doppler ultrasound shows an endoleak type Ib due to inaccurate connection between the main graft body and the left iliac extension](WIITM-14-33975-g002){#f0002}

On the other hand, CEUS is nowadays proposed as a routine diagnostic modality for follow-up after EVAR and should be extended by CT only when the ultrasound is positive \[[@cit0033]\]. Based on their recent meta-analysis that included 42 primary studies with 4220 participants, Abraha *et al.* calculated summary estimates in detecting endoleaks. US showed 0.72 sensitivity and 0.95 specificity whereas respective summary estimates for CEUS were 0.91 and 0.89. The CEUS is a technique using intravenous administered contrast agent with stabilized microspheres consisting of sulfur hexafluoride or perfluorocarbon encapsulated by a phospholipid shell. Microspheres do not affect renal function and are released via the respiratory tract. As the contrast medium has a very good safety profile, this modality can be used particularly in patients with contraindications to iodine and gadolinium-based contrast media that are used in CTA and magnetic resonance angiography (MRA). The CEUS presents detailed vascular morphology and enables real-time quantification of blood flow \[[@cit0034]\], which in some studies resulted in a higher specificity than that of CTA in endoleak classification \[[@cit0035]\]. In a recent retrospective study by Chisci *et al.* The CEUS was used as a reference method of follow-up \[[@cit0036]\]. In their material 318 CEUS examinations were performed with no procedure-related complications and allowed for 90% reduction in the number of CTAs, thereby reducing radiation exposure for patients.

Computed tomography angiography {#sec5.3}
-------------------------------

The CTA is the current reference standard and a workhorse for surveillance after EVAR \[[@cit0013], [@cit0037]\]. The CTA is widely available, less operator-dependent than US, and can be performed rapidly in unstable patients \[[@cit0037]\]. The superb spatial resolution of CTA enables precise measurement of aortic diameters and detection of both mechanical (stent graft kinking, migration, fracture) and soft tissue complications (inflammation, abscess formation, new aneurysms formation). However, due to inability to assess blood flow direction, CTA may present some limitations in endoleak classification \[[@cit0038]\].

Repeated follow-up CTAs in a patient after EVAR are related to a significant risk of contrast-induced acute kidney injury (CI-AKI) \[[@cit0039]\] and potentially carcinogenic cumulative radiation dose \[[@cit0040]\]. Patients after EVAR due to usually advanced age and frequent atherosclerosis present an increased risk for CI-AKI. Interestingly, we could not find any study published on kidney injury prevalence in this group. On the other hand, Maaniitty *et al.* found CI-AKI in 3.5% of in patients undergoing coronary CTA and permanent kidney injury in 0.2% \[[@cit0041]\]. In our opinion, these low numbers reflect contemporary common awareness of nephrotoxic properties of contrast media and widespread knowledge on the role of hydration before CTA \[[@cit0039]\]. The harmful effect of a radiation dose is much more difficult to assess due to the stochastic nature of carcinogenesis. Nyheim *et al.* examined the impact of age and follow-up regime over time on cumulative radiation exposure and attributable cancer risk after EVAR \[[@cit0040]\]. They suggested using a simplified surveillance protocol in younger patients as attributable cancer risk due to a 15-year follow-up was 0.65%. Bobadilla *et al.* proposed using a single unenhanced phase with real-time aneurysm sac volume calculation. In the case of significant (\> 2%) enlargement, further arterial and delayed phases are performed \[[@cit0042]\]. Another way to reduce radiation exposure is skipping the arterial phase when the main indication for imaging is endoleak suspicion \[[@cit0043]\].

Also dual-energy CT (DECT) is a promising technique in this regard, as it is able to retrospectively produce a so-called virtual unenhanced phase scanning the patient once, after contrast media administration. Therefore, DECT scanning results in 28--42% mean dose reduction with comparable diagnostic accuracy compared to biphasic single energy CTA \[[@cit0044], [@cit0045]\]. In another study, the effective dose reduction in DECT was 62% DECT compared to conventional triple-phase CTA with same diagnostic accuracy \[[@cit0046]\]. Another way of decreasing radiation exposure can be lowering the tube voltage from 120 to 80 kVp or even 80 kVp. In the study by Wintersperger *et al.* reduced tube voltage resulted in a mean dose reduction of 34% \[[@cit0047]\]. An advantage of low kVp imaging is increased image contrast, which allows for contrast medium dose reduction. A drawback is increased image noise that degrades overall image readability. A solution would be applying iterative or model-based image reconstructions \[[@cit0048]\]. These techniques use multiple advanced mathematical operations to optimize the image by reducing the noise. Iterative reconstructions are widely available in contemporary CT scanners and should be used routinely. Model-based reconstructions seem to be still a work-in-progress since the technology is expensive and time-consuming. However, it enables a 73% dose reduction as compared with low-dose conventional adaptive iterative reconstruction while maintaining diagnostic accuracy \[[@cit0049]\].

The diagnostic accuracy of CTA for detection of endoleaks is higher than that of digital subtraction angiography (DSA) and Doppler US \[[@cit0038]\]. However, one has to keep in mind that detection of endoleaks is strongly dependent on the scanning protocol. A traditional acquisition consists of an unenhanced phase, arterial phase, and 120-s delayed phase. The unenhanced phase allows for differentiation between endoleak and calcifications or embolizing material. The arterial phase allows for a detailed presentation of the aortic lumen and aortic branches as well as high-flow endoleaks. The delayed phase is aimed at visualization of slow-flow endoleaks ([Photo 3](#f0003){ref-type="fig"}). Some authors suggested using a 300-s delayed phase to present very low-flow endoleaks \[[@cit0050], [@cit0051]\]. The Eurostar study proposed performing only one delayed-phase CT with 3-mm slice thickness \[[@cit0052]\]. From our personal perspective three phases and thin reconstruction slices are necessary for reliable post-EVAR surveillance. A basic scanning protocol is presented in [Table I](#t0001){ref-type="table"}. However, we strongly suggest tailoring the parameters to reduce the radiation dose according to the scanner capability.

###### 

A basic CTA protocol for post-EVAR follow-up

  Parameter         Recommendations                                             Notes
  ----------------- ----------------------------------------------------------- ----------------------------------------------------------
  Coverage          From diaphragm to lower surface of pubic symphysis          
  Phases            Non-enhanced, arterial, delayed (60 s)                      Non-enhanced phase may be skipped if DECT is used
  Scan parameters   Slice 1 mm, pitch 1 mm, 120 kVp, automatic mAs adjustment   Available dose reduction techniques strongly recommended
  Contrast media    70 ml + 30 ml NaCl at 4 ml/s                                ≥ 350 mg I/ml
  Bolus tracking    Aorta at level of diaphragm                                 Threshold 120 HU, 8-s delay

![The CT in the post-EVAR surveillance in non-enhanced phase (**A**), 30-s arterial phase (**B**), and delayed 120-s phase (**C**). A type Ia endoleak is visible only in the delayed phase (arrow)](WIITM-14-33975-g003){#f0003}

The primary aim of follow-up is aneurysm size assessment as persistent growth after EVAR is a major risk factor of rupture. It is generally assumed that the size reduction indicates the successful functioning of the prosthesis but data on this subject remain inconclusive \[[@cit0053]\]. The most accurate assessment of the aneurysm can be obtained by evaluation of its volume. However, significant discrepancies between the assessment of maximal dimensions of the aneurysm and changes in its volume have been observed \[[@cit0054], [@cit0055]\]. In order to maintain adequate intraobserver and intraobserver reproducibility of measurements, lumen centerline curved planar reconstructions or at least 3D multiplanar reformations of image datasets are strongly recommended \[[@cit0056]\]. The CTA also enables a number of other image reconstruction possibilities including volume rendering (VR), shaded surface display (SSD) and virtual endoscopy (VE). In our opinion they do not increase the diagnostic accuracy of tomography but may be useful for initial recognition of aneurysm anatomy and as a tool for clinico-radiological consultations.

An important problem in post-EVAR surveillance using CTA is the presence of stent-related beam-hardening artifacts ([Photo 4](#f0004){ref-type="fig"}). Similar artifacts may be produced by coils, Lipiodol used as a component of embolic fluid, and the tantalum component of Onyx that are used for endoleak embolization. All these artifacts may obscure small leaks of contrast medium, but measurement of aneurysm sac size is still adequate \[[@cit0057]\]. DECT seemed to be a solution since it offers a projection-based iterative postprocessing method to reduce photon starvation, beam hardening and streak artifacts caused by metallic implants. However, despite better stent-graft visualization, recent studies have shown that this technique reduces small endoleak visualization \[[@cit0058]\].

![The CT in the post-EVAR surveillance. Stent-related blooming artifacts (arrow) hamper artery lumen evaluation (**A**). Photon-starving artifacts (arrow) may influence endoleak detection (**B**)](WIITM-14-33975-g004){#f0004}

Magnetic resonance angiography {#sec5.4}
------------------------------

Magnetic resonance angiography is a good alternative for post-EVAR follow-up, especially in patients with contraindications to iodinated contrast agents that are used in CTA. Another advantage of MRA is the lack of exposure to ionizing radiation. Limitations of MRA include its limited availability, high costs, and long scan time. Common contraindications to MRI include ferromagnetic implants and foreign bodies, electronic implants, and claustrophobia. However, in the case of implanted pacemakers or cardioverters/defibrillators it is worth considering the examination as modern devices are either MRI-compatible or MRI-conditionally compatible and successful scanning can be performed under specific conditions.

In patients with chronic kidney disease administration of gadolinium contrast media is related to risk of nephrogenic systemic fibrosis (NSF). In such patients, non-contrast enhanced MRA can be performed using steady state free precession T2-weighted sequences (e.g. FIESTA, TrueFISP, or Balanced-FFE) but at the cost of lower diagnostic accuracy \[[@cit0059]\]. Another potential limitation related to contrast media is recently discussed gadolinium retention in the globus pallidus, dentate nucleus, thalamus and pons \[[@cit0060], [@cit0061]\]. The retention is clearly related to MRI contrast media administration and is proportional to the cumulative gadolinium dose, which is important in long-term follow-up that requires repeated examinations. On the other hand, pathological significance of this phenomenon remains unknown. In a microscopic study no scarring or gliosis in the territory of accumulation was found \[[@cit0061]\]. Moreover, to date no clinical manifestations of gadolinium retention have been found.

The efficiency of MRA strongly depends on the graft material because metal-induced susceptibility artifacts can significantly reduce image quality ([Photo 5](#f0005){ref-type="fig"}). Nitinol endografts are most suitable for MRA surveillance, since Nitinol does not produce such artifacts. Also platinum coils used for endoleak embolization do not preclude MRA assessment \[[@cit0062]\]. Conversely, nickel-alloy and stainless-steel components should not be examined using MRA \[[@cit0063]\]. In patients with such devices the preferred imaging modality should be CTA or CEUS. We strongly recommend verification of the graft MRI compatibility using either the implant documentation or web bases of knowledge (e.g. <http://mrisafety.com>).

![Non-contrast enhanced MRI. Strong susceptibility artifacts produced by an aortic Zenith graft on axial (**A**) and sagittal (**B**) projection](WIITM-14-33975-g005){#f0005}

The most commonly used post-EVAR surveillance protocol consists of T1-weighted acquisition before and after contrast medium application in arterial and late phases. The arterial phase presents the aortic lumen and the late phase is recommended for endoleak detection \[[@cit0064]\]. A recent systematic review showed that MRI was more sensitive than CTA in detection of endoleaks, especially of type II \[[@cit0065]\]. In a group of 369 patients, 146 endoleaks were detected by CTA. The MRI detected all but two and also found 132 additional endoleaks compared to CTA. Therefore, MRI should be considered in patients with continued AAA growth and negative or uncertain findings in CTA. Detection of type II endoleaks is important due to the fact that with the increase in size of the aneurysm, they require immediate treatment \[[@cit0013]\].

Time-resolved MRA is a modification of the basic sequence in which high temporal resolution enables assessment of blood flow dynamics but at the cost of reduced spatial resolution and increased susceptibility artifacts \[[@cit0066], [@cit0067]\]. As a dynamic modality, it can be an alternative to invasive angiography in differentiation of the endoleak types \[[@cit0068], [@cit0069]\]. However, inferior spatial resolution may result in limited sensitivity to small leaks. Another method that increases sensitivity of MRA to endoleaks is the use of blood-pool contrast agents, which present prolonged intravascular retention \[[@cit0070]\]. Blood-pool media bind to albumin and have a blood half-life of approximately 15 h. They also have very high relaxivity. Therefore they have the potential to detect low-flow endoleaks that may be occult on CTA \[[@cit0070]\]. Low availability of blood-pool contrast media and advanced technical requirements have limited the use of this technique so far. Recently, four-dimensional non-contrast enhanced time-resolved phase contrast MRA was proposed for post-EVAR surveillance \[[@cit0071]\]. This technique is able to precisely present the bloodstream in the aorta and to analyze different hemodynamic and biomechanical forces acting on the intermodular connections of a multi-component stent graft using computational modeling \[[@cit0072]\]. As a dynamic modality, phase contrast MRA can be used for both the detection of endoleaks and the differentiation between endoleak types. Additionally it can show pathological, turbulent flow dynamics that predispose to thrombosis and endoleak \[[@cit0073], [@cit0074]\].

Despite its high sensitivity and specificity in endoleak detection, MRA has not yet become a routine method of post-EVAR surveillance. Apart from the above-mentioned common limitations of MRI, it seems that the challenging scanning protocol and the lack of expertise outside of major centers are the most important factors that restrict widespread use of MRA. On the other hand, MRI should be used to diagnose medullary ischemia, which may be a complication of EVAR \[[@cit0075]\].

Digital subtraction angiography {#sec5.5}
-------------------------------

The DSA is not recommended for the routine post-EVAR follow-up \[[@cit0007]\]. The main disadvantage of this modality is its invasiveness related to the artery puncture, the possibility of the vessel dissection or plaque mobilization, the significant radiation dose, and the intraarterial contrast medium application \[[@cit0076]\].

Compared to CTA, DSA presents significantly lower sensitivity in detecting endoleaks (92% vs. 63%, respectively) \[[@cit0077]\]. However, due to the dynamic nature of DSA, it allows for the assessment of blood flow direction and therefore it may be helpful in proper endoleak classification in selected cases. In CTA, contrast medium in lumbar arteries and inferior mesenteric arteries may result in problems in distinguishing between types I or III and type II. In a study by Stavropoulos *et al.* it was found that the use of DSA after CTA resulted in a significant change of diagnosed endoleak type and a change in treatment in 11% of patients \[[@cit0038]\].

Follow-up recommendations {#sec6}
=========================

Complications occurring in patients after EVAR are well documented, and the need for systematic surveillance seems to be clear \[[@cit0078]\]. Recommendations by the European Society for Vascular Surgery (ESVS) suggest that all patients should have computed tomography angiography (CTA) and plain radiographs with anteroposterior and lateral projections at 30 days after the procedure \[[@cit0013]\]. If there is any endoleak or less than one stent component or iliac overlap, CTA at 6 months and 12 months with plain radiographs should be done with adequate treatment if indicated. In patients with no early endoleak and good component overlap, the routine 6-month CTA could be omitted, but CTA and plain radiographs should be done after 1 year. At 12 months, if there is no endoleak and a stable or shrinking AAA, yearly Doppler US is recommended with plain radiographs using a standardized protocol with antero-posterior and lateral projections to assess device migration, stent fractures and modular disconnections. If the patient's body habitus precludes adequate US, then non-contrast CT with plain radiographs can be substituted. Any increasing aneurysm diameter or new endoleak, after prior negative imaging, should prompt complete imaging with CTA and plain radiographs.

However, it is worth mentioning that the presented recommendations are now 7 years old. Since their publication both stent graft quality and imaging techniques have improved significantly. Therefore, we believe there is a need for an update of guidelines with a reduced role of plain radiograms and increased application of US, including CEUS. On the other hand, recently Garg *et al*. suggested that less frequent imaging than suggested by ESVS guidelines was not associated with worse outcomes \[[@cit0079]\]. Other studies indicate that only up to 9% of patients actually benefit from surveillance imaging, as the imaging alone initiated secondary interventions in such a proportion of cases. That implies that more than 90% of post-EVAR patients received no benefits from follow-up \[[@cit0080], [@cit0081]\]. On the other hand, Leurs *et al.* reported that initially high-risk patients, despite more intensive imaging surveillance, had still more complications and higher mortality after EVAR \[[@cit0052]\]. Thus, individually scheduled follow-up instead of strict adherence to recommendations should be considered.

Personal perspective {#sec7}
====================

In clinical routine, CTA without a doubt remains the first line modality in post-EVAR surveillance because of its precision in diagnostics and availability. However, apart from DSA, CTA seems to be the most invasive modality due to exposure to radiation and potentially nephrotoxic contrast media. Therefore, in the time of personalized medicine, we should tailor diagnostic schedules both to receive accurate diagnosis and to reduce risk of complications.

Despite current recommendations of ESVS and its relative non-invasiveness, we should skip plain radiograph as it presents very limited diagnostic accuracy regarding the most clinically significant complications. From our personal perspective, Doppler US is an excellent tool for late follow-up in patients with no complications in the previous two or three CTAs. Such subjects present low probability of further stent-graft-related pathologies. On the other hand, significant endoleaks, which are worth treatment, are easily visible on US. The CEUS is a method with a special potential for post-EVAR surveillance. It presents sensitivity and specificity to endoleaks that are similar to CTA and an excellent safety profile. However, it requires high experience of the operator. Therefore, CEUS is an ideal modality for tertiary referral centers with high loads of patients. Finally, it is worth underlining the importance of clinico-radiological consultations, which are an essential part of contemporary patient management.

Conclusions {#sec8}
===========

Surveillance imaging is an important part of patient management after EVAR and CTA is the current first choice modality for follow-up. However, since current imaging recommendations seem not to adhere to current imaging possibilities, a more personalized approach is necessary with special attention paid to side effects of CTA and cost effectiveness.
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